Sg3 Management, LLC Kiniksa Pharmaceuticals, Ltd. Put Options Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$7.6 - $11.41 $304,000 - $456,400	-40,000 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$10.39 - $15.15 $415,600 - $606,000	40,000 New	40,000 $471,000
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $170,850 - $243,450	-15,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $753,540 - $1.09 Million	-57,000 Reduced 79.17%	15,000 $209,000
Q1 2021 May 17, 2021	BUY	$16.68 - $23.97 $700,560 - $1.01 Million	42,000 Added 140.0%	72,000 $1.33 Million
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $222,000 - $317,250	15,000 Added 100.0%	30,000 $530,000
Q3 2020 Nov 13, 2020	BUY	$15.21 - $25.53 $228,150 - $382,950	15,000 New	15,000 $230,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $761M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.